Oc
Octant Bio
Emeryville CAFounded 201840 employees
Private CapbiotechPrivateCNS
Platform: Multiplex GPCR
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mirituximab | OCT-4699 | Phase 2 | 1 | FcRn | MDSMG | ||
| OCT-7288 | OCT-7288 | Phase 2/3 | 1 | CD123 | ALSProstate Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (3)